{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T09:28:43Z","timestamp":1768642123984,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001794","name":"The University of Queensland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.vaccine.2012.11.051","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T14:29:10Z","timestamp":1354199350000},"page":"603-617","source":"Crossref","is-referenced-by-count":23,"title":["Systematic review of reporting rates of adverse events following immunization: An international comparison of post-marketing surveillance programs with reference to China"],"prefix":"10.1016","volume":"31","author":[{"given":"Biao","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.11.051_bib0005","doi-asserted-by":"crossref","first-page":"A84","DOI":"10.1016\/j.vaccine.2010.02.039","article-title":"The role of the China Experts Advisory Committee on Immunization Program","volume":"28","author":"Zheng","year":"2010","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0010","first-page":"242","article-title":"Measles epidemiological characteristics and progress of measles elimination in China, 2010","volume":"17","author":"Ma","year":"2011","journal-title":"Chin J Vaccines Immun"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2012.11.051_bib0015","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China\u2014declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"issue":"July (Suppl. 1)","key":"10.1016\/j.vaccine.2012.11.051_bib0020","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1093\/infdis\/jir103","article-title":"Progress toward measles elimination in the People's Republic of China, 2000\u20132009","volume":"204","author":"Ma","year":"2011","journal-title":"J Infect Dis"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.11.051_bib0025","first-page":"289","article-title":"Ministry of Health, Global Alliance for Vaccine and Immunization (GAVI) Cooperation Project. Evaluation on impact of hepatitis B vaccine integrated into routine immunization in the areas of China","volume":"15","author":"Cui","year":"2009","journal-title":"Chin J Vaccines Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.051_bib0030","first-page":"6","article-title":"Challenges, opportunities, and strategies on China National Immunization Program","volume":"12","author":"Guo","year":"2006","journal-title":"Chin J Vaccines Immun"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0035","unstructured":"China Ministry of Health. Technical standard operational procedures of Expanded Program on Immunization. Beijing; 1998."},{"issue":"December (6)","key":"10.1016\/j.vaccine.2012.11.051_bib0040","first-page":"553","article-title":"Thinking of China National Immunization Program information management system","volume":"16","author":"Cao","year":"2010","journal-title":"Chin J Vaccines Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.051_bib0045","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/erv.09.40","article-title":"Global safety of vaccines: strengthening systems for monitoring, management and the role of GACVS","volume":"8","author":"Zuber","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0050","series-title":"Regulations on appraisal and management of abnormal reactions following immunization","author":"China Ministry of Health","year":"1980"},{"issue":"February (7)","key":"10.1016\/j.vaccine.2012.11.051_bib0060","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa1008553","article-title":"Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China","volume":"364","author":"Liang","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.vaccine.2012.11.051_bib0065","first-page":"1331","article-title":"Bacille Calmette-Guerin vaccine-related disease in HIV-infected children: a systematic review","volume":"13","author":"Azzopardi","year":"2009","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.051_bib0070","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Zhang","year":"2011","journal-title":"Cochrane Libr"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.051_bib0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2334-11-13","article-title":"Efficacy and safety of prophylactic vaccines against cervical HPV infection and diseases among women: a systematic review & meta-analysis","volume":"11","author":"Lu","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"28","key":"10.1016\/j.vaccine.2012.11.051_bib0080","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/j.vaccine.2011.04.055","article-title":"Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review","volume":"29","author":"Thomas","year":"2011","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2012.11.051_bib0085","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/S0264-410X(03)00271-8","article-title":"Unintended events following immunization with MMR: a systematic review","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.051_bib0090","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1586\/erv.12.6","article-title":"Review of the risks and benefits of yellow fever vaccination including some new analyses","volume":"11","author":"Monath","year":"2012","journal-title":"Expert Rev"},{"issue":"February (1)","key":"10.1016\/j.vaccine.2012.11.051_bib0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1590\/S0034-89102011000100020","article-title":"Surveillance of adverse effects following vaccination and safety of immunization programs","volume":"45","author":"Waldman","year":"2011","journal-title":"Rev Saude Publica"},{"issue":"August","key":"10.1016\/j.vaccine.2012.11.051_bib0100","first-page":"5","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0105","series-title":"Immunization safety surveillance: guidelines for managers of immunization programmes on reporting and investigating adverse events following immunization","author":"World Health Organization","year":"1999"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2012.11.051_bib0110","first-page":"365","article-title":"Annual report: surveillance of adverse events following immunisation in Australia, 2008","volume":"33","author":"Menzies","year":"2009","journal-title":"Commun Dis Intell"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.11.051_bib0115","first-page":"49","article-title":"Supplementary report: surveillance of adverse events following immunisation among children aged less than seven years in Australia, 1 January to 30 June 2009","volume":"34","author":"Mahajan","year":"2009","journal-title":"Commun Dis Intell"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.11.051_bib0120","first-page":"27","article-title":"Supplementary report: surveillance of adverse events following immunisation among children aged<7 years in Australia, 1 January to 30 June 2008","volume":"33","author":"Lawrence","year":"2009","journal-title":"Commun Dis Intell"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0125","first-page":"248","article-title":"Annual report: surveillance of adverse events following immunisation in Australia, 2004","volume":"29","author":"Lawrence","year":"2005","journal-title":"Commun Dis Intell"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2012.11.051_bib0130","first-page":"379","article-title":"Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007","volume":"31","author":"Lawrence","year":"2007","journal-title":"Commun Dis Intell"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.11.051_bib0135","first-page":"269","article-title":"Annual report on surveillance of adverse events following immunisation in Australia, 2006","volume":"31","author":"Lawrence","year":"2007","journal-title":"Commun Dis Intell"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0140","first-page":"307","article-title":"Surveillance of adverse events following immunisation: Australia, 2000\u20132002","volume":"27","author":"Lawrence","year":"2003","journal-title":"Commun Dis Intell"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2012.11.051_bib0145","first-page":"371","article-title":"Annual report: surveillance of adverse events following immunisation in Australia, 2007","volume":"32","author":"Lawrence","year":"2008","journal-title":"Commun Dis Intell"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0150","first-page":"15","article-title":"Annual report: surveillance of adverse events following immunisation in Australia, 2005","volume":"30","author":"Lawrence","year":"2006","journal-title":"Commun Dis Intell"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0155","first-page":"324","article-title":"Surveillance of adverse events following immunisation: Australia 2002 to 2003","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.051_bib0160","first-page":"438","article-title":"Supplementary report: surveillance of adverse events following immunisation among children aged<7 years in Australia, 1 January to 30 June 2006","volume":"30","author":"Lawrence","year":"2006","journal-title":"Commun Dis Intell"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.051_bib0165","first-page":"413","article-title":"Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005","volume":"29","author":"Lawrence","year":"2005","journal-title":"Commun Dis Intell"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.051_bib0170","first-page":"490","article-title":"Surveillance of adverse events following immunisation for children aged less than 7 years, 1 January to 30 June 2004","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0175","series-title":"Statistical methods in medical research","author":"Armitage","year":"2002"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0180","unstructured":"China Ministry of Health. Implementation protocols on expanded National Immunization Program. Beijing; 2007, p. 11."},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.051_bib0185","first-page":"97","article-title":"Comparative study on post-marketing immunization safety of absorbed diphtheria, tetanus and acellular pertusis combined vaccine, and absorbed diphtheria, tetanus and whole-cell pertusis combined vaccine in China","volume":"14","author":"Liu","year":"2008","journal-title":"Chin J Vaccines Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.051_bib0190","first-page":"109","article-title":"Analysis on surveillance of adverse events following immunization for hepatitis B vaccine in China","volume":"17","author":"Xu","year":"2011","journal-title":"Chin J Vaccines Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.051_bib0195","first-page":"297","article-title":"Analysis on immunization safety in Shanghai in 2006","volume":"14","author":"Tao","year":"2008","journal-title":"Chin J Vaccines Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2012.11.051_bib0200","first-page":"40","article-title":"Analysis and evaluation on the surveillance data of adverse events following immunization in 2008 in Jiangsu province","volume":"38","author":"Zhang","year":"2010","journal-title":"Prog Microbiol Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.11.051_bib0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4161\/hv.7.2.13861","article-title":"Pertussis booster vaccine in China","volume":"7","author":"Zhu","year":"2011","journal-title":"Hum Vaccines"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0210","first-page":"233","article-title":"Survey on the immunization status of category B vaccine among children aged 1 to 2 years in China","author":"Zheng","year":"2012","journal-title":"Chin J Vaccines Immun"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2012.11.051_bib0215","first-page":"10","article-title":"NSW annual adverse events following immunisation report, 2009","volume":"21","author":"Mahajan","year":"2010","journal-title":"NSW Publ Health Bull"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.051_bib0220","first-page":"609","article-title":"Analysis on surveillance system of adverse events following immunization in Hainan province","volume":"26","author":"Zeng","year":"2010","journal-title":"Chin J Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.051_bib0225","first-page":"538","article-title":"Study on the surveillance of adverse events following immunization in Hebei province in 2005\u20132007","volume":"14","author":"Zhang","year":"2008","journal-title":"Chin J Vaccines Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.051_bib0230","first-page":"353","article-title":"Data analysis of national pilot surveillance of adverse events following immunization","volume":"13","author":"Guo","year":"2007","journal-title":"Chin J Vaccines Immun"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.11.051_bib0235","first-page":"38","article-title":"Vaccine-related adverse events in Cuban children, 1999\u20132008","volume":"14","author":"Galindo","year":"2012","journal-title":"Med Rev"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.051_bib0240","doi-asserted-by":"crossref","first-page":"474","DOI":"10.26719\/2010.16.5.474","article-title":"Surveillance of adverse events following immunization: 10 years\u2019 experience in Oman","volume":"16","author":"Awaidy","year":"2010","journal-title":"East Mediterr Health J"},{"issue":"January\/February","key":"10.1016\/j.vaccine.2012.11.051_bib0245","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4161\/hv.7.0.14613","article-title":"Consultancy and surveillance of post-immunisation adverse events in the Veneto region of Italy for 1992\u20132008","volume":"7","author":"Micheletti","year":"2011","journal-title":"Hum Vaccines"},{"issue":"May (24)","key":"10.1016\/j.vaccine.2012.11.051_bib0250","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.vaccine.2010.04.002","article-title":"Surveillance for adverse events following immunization (AEFI) in Switzerland\u20141991\u20132001","volume":"28","author":"Schumacher","year":"2010","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.11.051_bib0255","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)\u2014United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Recomm Rep Surveil Summ"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.051_bib0260","first-page":"481","article-title":"Analysis on the surveillance of adverse events following immunization in China, 2007\u20132008","volume":"15","author":"Wu","year":"2009","journal-title":"Chin J Vaccines Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.051_bib0265","first-page":"99","article-title":"Analysis on adverse events following immunization surveillance in China, 2009","volume":"17","author":"Wu","year":"2011","journal-title":"Chin J Vaccines Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2012.11.051_bib0270","first-page":"505","article-title":"Study on the surveillance of adverse events following immunization in China, 2005\u20132006","volume":"13","author":"Liu","year":"2007","journal-title":"Chin J Vaccines Immun"},{"issue":"May (25\u201326)","key":"10.1016\/j.vaccine.2012.11.051_bib0275","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1016\/j.vaccine.2009.01.059","article-title":"Vaccine adverse event monitoring systems across the European Union countries: time for unifying efforts","volume":"27","author":"Zanoni","year":"2009","journal-title":"Vaccine"},{"issue":"March (17\u201318)","key":"10.1016\/j.vaccine.2012.11.051_bib0280","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.vaccine.2005.01.022","article-title":"Surveillance system of vaccine adverse events and local data analysis\u2014the experience in a middle-sized city in Brazil, 1999\u20132001","volume":"23","author":"Fernandes","year":"2005","journal-title":"Vaccine"},{"issue":"18","key":"10.1016\/j.vaccine.2012.11.051_bib0285","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1016\/j.vaccine.2010.02.059","article-title":"Surveillance for adverse events after DTwP\/Hib vaccination in Brazil: sensitivity and factors associated with reporting","volume":"28","author":"Monteiro","year":"2010","journal-title":"Vaccine"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2012.11.051_bib0290","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/S0264-410X(00)00515-6","article-title":"Inactivated poliovirus vaccine and the final stages of poliovirus eradication","volume":"19","author":"Hovi","year":"2001","journal-title":"Vaccine"},{"issue":"39","key":"10.1016\/j.vaccine.2012.11.051_bib0295","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.1016\/j.vaccine.2008.07.026","article-title":"World wide experience with inactivated poliovirus vaccine","volume":"26","author":"Bonnet","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.11.051_bib0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.biologicals.2006.03.003","article-title":"Post-eradication poliovirus facility-associated community risks","volume":"34","author":"Dowdle","year":"2006","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0305","first-page":"89","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Zhang","year":"2011","journal-title":"Cochrane Libr"},{"issue":"3","key":"10.1016\/j.vaccine.2012.11.051_bib0310","first-page":"89","article-title":"Acellular vaccines for preventing whooping cough in children","author":"Zhang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2012.11.051_bib0315","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1016\/j.vaccine.2006.11.008","article-title":"Safety of a combination diphtheria, tetanus toxoid, acellular pertussis, hepatitis B, and inactivated polio vaccine coadministered with a 7-valent pneumococcal conjugate vaccine and a Haemophilus influenzae type b conjugate vaccine","volume":"25","author":"Partridge","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0320","series-title":"Adverse events in the Netherlands vaccination programme: number VIII reports in 2001: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2003"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0325","series-title":"Adverse events in the Netherlands vaccination programme: number VII reports in 2000: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2002"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0330","series-title":"Adverse events in the Netherlands vaccination programme: number III\u2013IV reports in 1996 and 1997: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2001"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0335","series-title":"Adverse events in the Netherlands vaccination programme: number V reports in 1998: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2001"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0340","series-title":"Adverse events in the Netherlands vaccination programme: number VI reports in 1999: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2001"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0345","series-title":"Adverse events in the Netherlands vaccination programme: number IX reports in 2002: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2004"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0350","series-title":"Adverse events in the Netherlands vaccination programme: number X reports in 2003: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2004"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0355","series-title":"Adverse events in the Netherlands vaccination programme: number XI reports in 2004: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2005"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0360","series-title":"Adverse events in the Netherlands vaccination programme: reports in 2010 and review 1994\u20132010: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2011"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0365","series-title":"Adverse events in the Netherlands vaccination programme: number II reports in 1995: National Institute for Public Health and the Environment","author":"Vermeer-de Bondt","year":"2001"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0370","series-title":"Adverse events in the Netherlands vaccination programme: number XIII reports in 2006: National Institute for Public Health and the Environment","author":"van der Maas","year":"2007"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0375","series-title":"Adverse events in the Netherlands vaccination programme: number XII reports in 2005: National Institute for Public Health and the Environment","author":"van der Maas","year":"2006"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0380","series-title":"Adverse events in the Netherlands vaccination programme: number XVI-reports in 2009: National Institute for Public Health and the Environment","author":"van der Maas","year":"2010"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0385","series-title":"Adverse events in the Netherlands vaccination programme: number XV-reports in 2008: National Institute for Public Health and the Environment","author":"van der Maas","year":"2009"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0390","series-title":"Adverse events in the Netherlands vaccination programme: number XIV-reports in 2007: National Institute for Public Health and the Environment","author":"van der Maas","year":"2008"},{"key":"10.1016\/j.vaccine.2012.11.051_bib0395","series-title":"Global network for postmarketing surveillance and AEFI monitoring","author":"World Health Organization","year":"2012"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.11.051_bib0400","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5694\/j.1326-5377.2003.tb05497.x","article-title":"Local reactions after the fourth dose of acellular pertussis vaccine in South Australia","volume":"179","author":"Gold","year":"2003","journal-title":"Med J Aust"},{"issue":"5","key":"10.1016\/j.vaccine.2012.11.051_bib0405","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1001\/archpedi.1996.02170300011001","article-title":"The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine: a postmarketing assessment","volume":"150","author":"Rosenthal","year":"1996","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:19:27Z","timestamp":1594959567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12016659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":80,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0264410X12016659"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.051","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}